COVID-19 Does Not Influence the Time to Relapse Following Dupilumab Discontinuation in Patients With Moderate-to-Severe Atopic Dermatitis
Dermatitis
.
2023 Dec 29.
doi: 10.1089/derm.2023.0304.
Online ahead of print.
Author
Xiu-Kun Sun
1
Affiliation
1
Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital of Zhejiang University School of Medicine, Hangzhou, China.
PMID:
38156808
DOI:
10.1089/derm.2023.0304
No abstract available